Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mitogen-activated protein kinase phosphatase 3
(
MKP-3
) is a negative regulator of extracellular signal-related kinase signaling. Our laboratory recently demonstrated that
MKP-3
plays an important role in
obesity
-related hyperglycemia by promoting hepatic glucose output. This study shows that
MKP-3
deficiency attenuates body weight gain induced by a high-fat diet (HFD) and protects mice from developing
obesity
-related hepatosteatosis. Triglyceride (TG) contents are dramatically decreased in the liver of
MKP-3
(-/-) mice fed an HFD compared with wild-type (WT) controls. The absence of
MKP-3
also reduces adiposity, possibly by repressing adipocyte differentiation. In addition,
MKP-3
(-/-) mice display increased energy expenditure, enhanced peripheral glucose disposal, and improved systemic insulin sensitivity. We performed global phosphoproteomic studies to search for downstream mediators of
MKP-3
action in liver lipid metabolism. Our results revealed that
MKP-3
deficiency increases the phosphorylation of histone deacetylase (HDAC) 1 on serine 393 by 3.3-fold and HDAC2 on serine 394 by 2.33-fold. Activities of HDAC1 and 2 are increased in the livers of
MKP-3
(-/-) mice fed an HFD. Reduction of HDAC1/2 activities is sufficient to restore TG content of
MKP-3
(-/-) primary hepatocytes to a level similar to that in WT cells.
...
PMID:Mitogen-activated protein kinase phosphatase 3 (MKP-3)-deficient mice are resistant to diet-induced obesity. 2472 45
Brown fat has been highlight as a new therapeutic target for treatment of
obesity
and diabetes. However, molecular mechanism underlying brown adipogenesis are not fully understood. Here, we identified that
MAP kinase phosphatase 3
(
MKP3
) has a novel role as regulator of brown adipocyte differentiation. The expression of
MKP3
was significantly decreased during the early stage(s) of brown adipocyte differentiation in HIB-1B cells and primary cells. Ectopic expression of
MKP3
led to reduced brown adipocyte differentiation, whereas depletion of
MKP3
significantly enhanced the differentiation of primary brown preadipocytes. Consistently, we found an increased brown adipocyte differentiation in
MKP3
-null MEF cells. These inhibitory effects of
MKP3
could be resulted via the temporal regulation of Erk activation. In recent, it was reported that
MKP3
deficient mice are resistant to diet-induced
obesity
, and display enhanced energy expenditure. Taken together, we suggest that
MKP3
could be an important factor in the regulation of brown adipocyte differentiation.
...
PMID:MAP kinase phosphatase 3 inhibits brown adipocyte differentiation via regulation of Erk phosphorylation. 2632 40